Ellomay Capital Ltd. filings document a foreign private issuer focused on renewable energy and power generation and development in Europe, the United States and Israel. Its Form 20-F and Form 6-K reports disclose operating and financial results, project development costs, portfolio holdings, and securities listed on the NYSE American and the Tel Aviv Stock Exchange.
The company’s regulatory record also covers material-event disclosures tied to asset sales, Ellomay Luzon Energy Infrastructures Ltd., Dorad Energy Ltd., and capital-structure matters involving Series E Secured Debentures, collateral and repayment notices. Governance filings include principal shareholder changes, board composition updates, registration-statement incorporation by reference, and risk-related forward-looking statement disclosures.
Ellomay Capital Ltd. (ELLO) reported that the first 30 MW of the 87 MW solar facility built by its 51%-owned Italian subsidiary, Ellomay Solar Italy Five S.r.l., connected to Italy’s national grid on October 6, 2026, and began producing energy. The facility is located in Italy’s Lazio Region.
The remaining 57 MW is expected to connect to the grid in the coming weeks. For the full 87 MW facility, expected P50 aggregate annual production is approximately 160 GWh/year.
Ellomay Capital Ltd. announced that its indirectly held wholly-owned Spanish subsidiary, Ellomay Solar S.L., received a battery storage grid access and connection permit for a project with capacity for up to 22.2 MW / 100.3 MWh (4.5-hour). The project also received a permit to charge 22.2 MW of electricity from the grid.
The BESS Facility will be built on land already leased to Ellomay Solar, which owns a 28 MWp solar facility in Talaván, Cáceres, Spain. Ellomay currently expects construction to commence in the beginning of 2027 and be completed in the fourth quarter of 2027.
Ellomay Capital Ltd. (ELLO) reports that Midroog Ltd., an Israeli rating agency affiliated with Moody’s Investors Service, has reaffirmed its credit rating of Baa1.il with a “Stable” outlook for the company. Midroog’s Hebrew-language rating report is available on the Tel Aviv Stock Exchange’s Maya system, and an unofficial English translation will be posted in the investors section of Ellomay Capital’s website.
The company also includes standard cautionary language about forward-looking statements, highlighting risks related to electricity prices and demand, regulatory changes, interest rates and inflation, resource prices, geopolitical conflicts, project development and permitting, climate change, and economic conditions in Israel, Spain, Italy and the United States.
Ellomay Capital Ltd. (ELLO) reported strong headline results for the six months ended June 30, 2026, driven by the sale of its indirect stake in Dorad Energy. Revenues from ongoing operations were about €21.1 million, slightly above the prior year’s €20.1 million, mainly due to biogas activity in the Netherlands, while lower Spanish electricity prices and Italian PPAs weighed on some solar revenues.
The company recorded a net profit of €58.3 million, compared with a small loss a year earlier, but this was dominated by a €83.3 million profit from discontinued operations related to the Dorad sale. Continuing operations showed a loss of €25.0 million, largely reflecting substantial FX-driven finance expenses. EBITDA for the half-year rose sharply to €90.6 million from €6.1 million. Ellomay executed an early full repayment of its Series E debentures and ended June 2026 with cash and cash equivalents of €113.5 million plus €53.3 million of short-term deposits, and reported Net Financial Debt of about €50.9 million, with debenture covenants comfortably met.
Operationally, Ellomay advanced solar and storage projects in Italy, the USA and Spain, expanded biogas capacity in the Netherlands, and continued construction at the Manara pumped storage project in Israel, while noting potential schedule risks from ongoing regional hostilities and pending compensation and financing adjustments.
Phoenix Financial Ltd., an Israeli entity, reports beneficial ownership of 97,964.06 Ordinary Shares of Ellomay Capital Ltd., representing 0.71% of the class, based on 13,783,230 Ordinary Shares outstanding as of August 2, 2026 (as reported on Bloomberg LP). The shares are Ellomay Ordinary Shares with par value NIS 10.00 per share.
As of July 31, 2026, these holdings were spread across Phoenix group subsidiaries, including 27,455.06 shares held by The Phoenix Investments House trust funds, 16,510 shares in Phoenix “nostro” accounts, 32,374 shares in a partnership for Israeli shares, and 21,625 shares in a partnership for investing in share indexes. Phoenix states that each subsidiary has independent management and makes its own voting and investment decisions, and it disclaims group status and beneficial ownership beyond actual pecuniary interest.
Ellomay Capital Ltd. is the issuer of ordinary shares, par value NIS 10.00 per share, held under CUSIP M39927120. Menora Mivtachim Holdings Ltd. and Menora Mivtachim Pensions and Gemel Ltd., both organized in Israel, report their beneficial ownership in these shares.
As of July 31, 2026, Menora Mivtachim Pensions and Gemel Ltd., Menora Mivtachim Insurance Ltd., and Menora Mivtachim Vehistadrut Hamehandesim Nihul Kupot Gemel Ltd. each held 0 ordinary shares, representing 0% of Ellomay Capital’s outstanding ordinary shares. Voting and dispositive power for each reporting person is reported as 0. The percentage calculation is based on 13,783,230 ordinary shares outstanding as of August 2, 2026. The reporting entities note that many securities are held economically for the benefit of insurance policy holders, portfolio account owners, and members of provident and pension funds, and they disclaim beneficial ownership except to the extent of their pecuniary interest.
Ellomay Capital director Ben Simon Dorit received an annual grant of 1,000 stock options on August 1, 2026 under the issuer's 1998 Share Option Plan for Non-Employee Directors. The options cover 1,000 Ordinary Shares, have an exercise price of 19.6000, first become exercisable on August 1, 2027, and expire on August 1, 2036, subject to her continued board service.
Ellomay Capital Ltd. director Odelya Ohayon received an annual grant of 1,000 stock options on August 1, 2026 under the 1998 Share Option Plan for Non-Employee Directors. The options cover 1,000 ordinary shares at an exercise price of 19.6000 per share, become exercisable on August 1, 2027, expire on August 1, 2036, and are subject to her continuing to serve on the board on the exercisability date.
Ellomay Capital Ltd. director Daniel Vaknin received an annual grant of 1,000 stock options on August 1, 2026 under the Issuer's 1998 Share Option Plan for Non-Employee Directors. The options have a $19.60 exercise price, become exercisable August 1, 2027, are subject to his continued board service on that date, and expire August 1, 2036, leaving him with 1,000 options.
Ellomay Capital Ltd. director Gilad Mamlok received an annual grant of stock options on August 1, 2026 under the 1998 Share Option Plan for Non-Employee Directors. The award covers 1,000 options to buy 1,000 Ordinary Shares at an exercise price of 19.60 per share, becoming exercisable on August 1, 2027 and expiring on August 1, 2036, subject to his continued board service on the exercise date.